In line with World Immunization Week, we’ve brought together a panel of experts to discuss the issues surrounding vaccine confidence in a ‘post-truth’ world.
Browsing: Research > Clinical
A large-scale trial of RTS,S – the world’s first malaria vaccine to provide partial protection – is due to commence in Malawi, Kenya and Ghana.
Vaccine-preventable diseases – including measles and diphtheria – have surged in crisis-hit Venezuela, according to research presented at ECCMID.
A huge upsurge in malaria cases has been caused by Venezuela’s socioeconomic and political crisis, undoing years of progress and endangering neighbouring countries, according to research presented at ECCMID.
Men and women have different risks of developing surgical site infections depending on the type of operation they undergo, according to new research being presented at ECCMID.
Collaborative research efforts have seen a novel monoclonal antibody, suvratoxumab, complete a Phase II trial targeted towards Staphylococcus aureus. This SAATELLITE study comes as the first clinical trial in the Innovative Medicines Initiative, formed to develop alternative medicines to combat antibiotic resistance.
A shortened 15 second application time and a simpler three-step method for alcohol-based hand rub is as effective in reducing bacteria as the 30-second, six-step technique recommended by the WHO, according to research presented at ECCMID.
Research presented at ECCMID has suggested healthcare workers on intensive care units (ICUs) are regularly missing opportunities to clean their hands during patient care.
Staying in a hotel or private accommodation has been associated with carrying ESBL-producing bacteria in travelers to low- and middle-income countries, according to research presented at ECCMID.
New research presented at ECCMID has identified a novel association between antimicrobial resistance and climatic factors in Europe.